ニュース

Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues. There are more than 200 different types of cancer. 1 in 2 people in the UK will get ...
This study looked at taselisib and palbociclib for breast cancer when other treatments have stopped working. It was only for women with a change in a gene called PIK3CA. This trial was open for people ...
This study is asking people about their experiences of having radiotherapy for prostate or breast cancer. It is also asking them about their travel to hospital to find out about the impact of ...
Tests on your bowel cancer cells After a doctor removes tissue or cancer from your bowel, they send a sample of cells to the laboratory. A doctor called a pathologist does various tests on the cells.
This study is looking at improving the ASICA melanoma app to better support people to check their skin monthly. It is for people who have had treatment for melanoma that hadn’t spread and there have ...
We know that squamous cell lung cancer takes glucose (a sugar) from the blood to help it grow and protect itself. Researchers think that by lowering the amount of glucose available to cancer cells ...
Share your experience of cancer If you’ve been affected by cancer, whether personally or through someone you love, your experience can help shape the future of care and research. Join the Cancer ...
This trial started in 2014 and these results were published in 2016. Researchers wanted to find out whether nivolumab helped people with Hodgkin lymphoma that had come back after a stem cell ...
Please note - this trial is no longer recruiting patients. We hope to add results when they are available. Women with HER2 negative breast cancer do not benefit from certain types of biological ...
Read the full video transcript. Randomised trials have at least 2 different treatment groups. The people taking part are put into one of the groups at random. This process is called 'randomisation' ...
This trial is comparing two treatments for non small cell lung cancer. The first treatment is atezolizumab and tiragolumab. The other treatment is durvalumab. It is for people with non small cell lung ...